Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity?
- PMID: 16840182
- DOI: 10.1080/10428190600593125
Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity?
Comment on
-
Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.Leuk Lymphoma. 2006 Jun;47(6):998-1005. doi: 10.1080/10428190600563821. Leuk Lymphoma. 2006. PMID: 16840188 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources